SCHEMBL4194953

SCHEMBL4194953

C[C@@H](CC1CCCC1)NCc1ccccc1NS(=O)(=O)c1ccc(NS(=O)(=O)c2cn(C)cn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
PKM P14618 1/20 0.42
PIK3CG P48736 6/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
IRS1 P35568 1/20 0.41
GAB1 Q13480 1/20 0.41
LMNA P02545 4/20 0.40
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GLO1 Q04760 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.37
MAPT P10636 1/20 0.36
PARP1 P09874 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193042 0.99 KDM4E (0.45) KDM4EPKMPIK3CGGAATSHR
SCHEMBL4195588 0.93 KDM4E (0.52) KDM4EPKMPIK3CGGAAIRS1
SCHEMBL4197418 0.92 KDM4E (0.51) KDM4EPKMPIK3CGGAAIRS1
SCHEMBL4193193 0.90 KDM4E (0.44) KDM4EPKMPIK3CGGAAIRS1
SCHEMBL4199715 0.90 KDM4E (0.45) KDM4EPKMPIK3CGGAATSHR
SCHEMBL4198102 0.88 KDM4E (0.47) KDM4EPKMPIK3CGGAAIRS1
SCHEMBL4198320 0.88 TSHR (0.44) KDM4EPKMPIK3CGGAATSHR
SCHEMBL4200124 0.85 PIK3CG (0.45) KDM4EPIK3CGGAAKMT2A
SCHEMBL4190722 0.83 KDM4E (0.42) KDM4EPKMLMNAALDH1A1SMN1; SMN2
SCHEMBL4190913 0.83 KDM4E (0.50) KDM4EPKMGAATSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885PIK3CG 1756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.